A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://link.springer.com/doi/10.1007/s12640-010-9192-0 below:

Stereotypic Progressions in Psychotic Behavior

  • Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231:343–354

    CAS  PubMed  Google Scholar 

  • Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA (1985a) Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by l-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J Pharmacol Exp Ther 235:287–295

    CAS  PubMed  Google Scholar 

  • Breese GR, Napier TC, Mueller RA (1985b) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447–455

    CAS  PubMed  Google Scholar 

  • Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA (1987) 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240:167–176

    CAS  PubMed  Google Scholar 

  • Brunton LL, Lazo JS, Parker KL (2006) Goodman & Gilman’s the Pharmacological Basis of Therapeutics, 11th edn. McGraw Hill, New York

    Google Scholar 

  • Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 268:231–237

    CAS  PubMed  Google Scholar 

  • Brus R, Plech A, Kostrzewa RM (1995) Enhanced quinpirole responses in rats lesioned neonatally with 5,7-dihydroxytryptamine. Pharmacol Biochem Behav 50:649–653

    Article  CAS  PubMed  Google Scholar 

  • Brus R, Szkilnik R, Kostrzewa RM (1997) Quinpirole-induced yawning behavior in rats neonatally pretreated with 6-hydroxydopamine (6-OHDA) and 5,7-dihydroxytryptamine (5,7-DHT). Med Sci Monitor 3:324–327

    CAS  Google Scholar 

  • Brus R, Szkilnik R, Nowak P, Kasperska A, Oswiecimska J, Kostrzewa RM, Shani J (1998) Locomotor sensitization of dopamine receptors by their agonists quinpirole and SKF-38393, during maturation and aging in rats. Pharmacol Rev Commun 10:25–30

    CAS  Google Scholar 

  • Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP (2003) Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Neurotox Res 5(5):329–338

    Article  PubMed  Google Scholar 

  • Brus R, Nowak P, Szkilnik R, Mikołajun U, Kostrzewa RM (2004) Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox Res 6:317–325

    Article  PubMed  Google Scholar 

  • Criswell H, Mueller RA, Breese GR (1989) Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J Neurosci 9:125–133

    CAS  PubMed  Google Scholar 

  • Gong L, Kostrzewa RM (1992) Supersensitized oral response to a serotonin agonist in neonatal 6-OHDA treated rats. Pharmacol Biochem Behav 41:621–623

    Article  CAS  PubMed  Google Scholar 

  • Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000–1007

    CAS  PubMed  Google Scholar 

  • Gong L, Kostrzewa RM, Brus R, Fuller RW, Perry KW (1993a) Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Dev Brain Res 76:59–65

    Article  CAS  Google Scholar 

  • Gong L, Kostrzewa RM, Perry KW, Fuller RW (1993b) Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev Brain Res 76:233–238

    Article  CAS  Google Scholar 

  • Gong L, Kostrzewa RM, Li C (1994) Neonatal 6-OHDA and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J Neurochem 63:1282–1290

    Article  CAS  PubMed  Google Scholar 

  • Haile CN, Kosten TR, Kosten TA (2009) Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse 35:161–177 (Review)

    Article  PubMed  Google Scholar 

  • Hamdi A, Kostrzewa RM (1991) Ontogenic homologous supersensitization of dopamine D1 receptors. Eur J Pharmacol 203:115–120

    Article  CAS  PubMed  Google Scholar 

  • Hermens DF, Lubman DI, Ward PB, Naismith SL, Hickie IB (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(4 Suppl):S22–S25 Review

    PubMed  Google Scholar 

  • Huang N-Y, Kostrzewa RM, Li C, Perry KW, Fuller RW (1997) Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280:268–276

    CAS  PubMed  Google Scholar 

  • Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19:1–17

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Brus R (1991a) Is dopamine-agonist induced yawning behavior a D3 mediated event? Pharmacol Lett Section Life Sci 48: PL-129.

    Google Scholar 

  • Kostrzewa RM, Brus R (1991b) Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol Biochem Behav 39:517–519

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Gong L (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol Biochem Behav 39:677–682

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Hamdi A (1991) Potentiation of spiroperidol-induced oral activity in rats after neonatal 6-hydroxydopamine. Pharmacol Biochem Behav 38:215–218

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Neely D (1993) Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats. Pharmacol Biochem Behav 45:737–740

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Hamdi A, Kostrzewa FP (1990) Production of prolonged supersensitization of dopamine D2 receptors. Eur J Pharmacol 183:1411–1412

    Article  Google Scholar 

  • Kostrzewa RM, Brus R, Kalbfleisch J (1991) Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats. Eur J Pharmacol 209:157–161

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Brus R, Rykaczewska M, Plech A (1993a) Low dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol Biochem Behav 44:487–489

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Guo J, Kostrzewa FP (1993b) Ontogenetic quinpirole treatments induce vertical jumping activity in rats. Eur J Pharmacol 239:183–187

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Brus R, Perry KW, Fuller RW (1993c) Age-dependence of a 6-hydroxydopamine lesion on SKF 38393-, m-chlorophenylpiperazine-induced oral activity responses of rats. Dev Brain Res 76:87–93

    Article  CAS  Google Scholar 

  • Kostrzewa RM, Brus R, Kalbflesich JH, Perry KW, Fuller RW (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161–167

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Reader TA, Descarries L (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J Neurochem 70:889–898

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Kostrzewa JP, Brus R (2003) Dopamine receptor supersensitivity: an outcome and index of neurotoxicity. Neurotox Res 5:111–118

    Article  PubMed  Google Scholar 

  • Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2004) Dopamine D2 agonist priming in intact and dopamine-lesioned rats. Neurotox Res 6:457–462

    Article  PubMed  Google Scholar 

  • Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2005) Peculiarities of l-DOPA treatment of Parkinson’s disease. Amino Acids 28:157–164

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Huang N-Y, Kostrzewa JP, Nowak P, Brus R (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11(1):41–50

    Article  CAS  PubMed  Google Scholar 

  • Kostrzewa RM, Kostrzewa JP, Brown R, Nowak P, Brus R (2008) Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability. Neurotox Res 14:121–128

    Article  CAS  PubMed  Google Scholar 

  • Moy SS, Fernandes A, Qian Y, Rotella DL, Kostrzewa RM, Breese GR (2004) Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss. Pharmacol Biochem Behav 78:47–56

    Article  CAS  PubMed  Google Scholar 

  • Nowak P, Brus R, Kostrzewa RM (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol 53:319–329

    CAS  PubMed  Google Scholar 

  • Nowak P, Labus Ł, Kostrzewa RM, Brus R (2006) DSP-4 prevents dopamine receptor priming by quinpirole. Pharmacol Biochem Behav 84:3–7

    Article  CAS  PubMed  Google Scholar 

  • Nowak P, Bortel A, Dabrowska J, Oswiecimska J, Drosik M, Kwiecinski A, Opara J, Kostrzewa RM, Brus R (2007) Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox Res 11:131–144

    Article  CAS  PubMed  Google Scholar 

  • Nowak P, Bortel A, Kwieciński A, Jośko J, Kostrzewa RM, Brus R (2009a) Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists. Pharm Rep 57:311–318

    Google Scholar 

  • Nowak P, Nitka D, Kwieciński A, Jośko J, Drab J, Pojda-Wilczek D, Kasperski J, Kostrzewa RM, Brus R (2009b) Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists. Pharm Rep 61:311–318

    CAS  Google Scholar 

  • Oswiecimska J, Brus R, Szkilnik R, Nowak P, Kostrzewa RM (2000) 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats. Pharmacol Biochem Behav 67:11–15

    Article  CAS  PubMed  Google Scholar 

  • Palomo T, Kostrzewa RM, Beninger RJ, Archer T (2008) Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyringhs. Neurotox Res 14:79–96

    Article  CAS  PubMed  Google Scholar 

  • Plech A, Brus R, Kalbfleisch JH, Kostrzewa RM (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology 119:466–473

    Article  CAS  PubMed  Google Scholar 

  • Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naïve rats by D1 stimulation. Life Sci 33:2479–2482

    Article  CAS  PubMed  Google Scholar 

  • Rosengarten H, Schweitzer JW, Egawa J, Friedhoff AJ (1986) Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. Adv Exp Med Biol 235:159–167

    Google Scholar 

  • Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133–152

    Article  CAS  PubMed  Google Scholar 

    • RetroSearch is an open source project built by @garambo | Open a GitHub Issue

    Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

    HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4